Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020– December 2023.

MLA

Schwarz, Evan S., et al. “Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020– December 2023.” MMWR: Morbidity & Mortality Weekly Report, vol. 73, no. 30, Aug. 2024, pp. 672–74. EBSCOhost, https://doi.org/10.15585/mmwr.mm7330a3.

APA

Schwarz, E. S., Buchanan, J., Aldy, K., Shulman, J., Krotulski, A., Walton, S., Logan, B., Wax, P., Campleman, S., Brent, J., Culbreth, R., & Manini, A. F. (2024). Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020– December 2023. MMWR: Morbidity & Mortality Weekly Report, 73(30), 672–674. https://doi.org/10.15585/mmwr.mm7330a3

Chicago

Schwarz, Evan S., Jennie Buchanan, Kim Aldy, Joshua Shulman, Alex Krotulski, Sara Walton, Barry Logan, et al. 2024. “Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020– December 2023.” MMWR: Morbidity & Mortality Weekly Report 73 (30): 672–74. doi:10.15585/mmwr.mm7330a3.